Efficacy of add-on topiramate therapy in psychiatric patients with weight gain

Annals of Pharmacotherapy

Volumn 42, Issue 4, 2008, Pages 505-510

  Cates, Marshall E ^a   Feldman, Jacqueline M ^b   Boggs, Angela A ^c   Woolley, Thomas W ^a   Whaley, Nanci P ^d  

^a SAMFORD UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d Walgreen   (United States)

Author keywords

Body weight; Psychotropic drugs; Topiramate

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; TOPIRAMATE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; INCREASED APPETITE; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MENTAL HEALTH CENTER; MENTAL PATIENT; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TASTE DISORDER; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANTI-OBESITY AGENTS; BODY MASS INDEX; COMMUNITY MENTAL HEALTH CENTERS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 42049096986     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K520     Document Type: Article

References (15)

1. Masand PS. Weight gain associated with psychotropic drugs. Expert Opin Pharmacother 2000;1:377-89.
2. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601.
3. Arnone D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry 2005;4:5.
4. Astrup A, Toubro S. Topiramate: a new potential pharmacological treatment for obesity. Obes Res 2004;12(suppl):167S-73S.
5. Lin YH, Liu CY, Hsiao MC. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate. Psychiatry Clin Neurosci 2005;59:613-5.
6. Lévy E, Agbokou C, Ferreri F, Chouinard G, Margolese HC. Topiramate-induced weight loss in schizophrenia: a retrospective case series study. Can J Clin Pharmacol 2007;14:e234-9.
7. Kirov G, Tredget J. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series. BMC Psychiatry 2005;5:19.
8. Canitano R. Clinical experience with topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders. Brain Dev 2005;27:228-32.
9. Van Ameringen M, Mancini C, Pipe B, Campbell M, Oakman J. Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J Clin Psychiatry 2002;63:981-4.
10. Tramontina S, Zeni CP, Pheula G, Rohde LA. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial. J Child Adolesc Psychopharmacol 2007;17:129-34.
11. Gabriel A. Adjunctive topiramate treatment in refractory obese bipolar patients: a descriptive open label study. Eat Weight Disord 2007;12:48-53.
12. Nickel MK, Nickel C, Muehlbacher M, et al. Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study. J Clin Psychopharmacol 2005;25:211-7.
13. Ko YH, Joe SH, Jung IK, Kim SH. Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain. Clin Neuropharmacol 2005;28:169-75.
14. McElroy SL, Frye MA, Altshuler LL, et al. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. Bipolar Disord 2007;9:426-34.
15. Kowacs PA, Piovesan EJ, Ribas LC, Fameli H, Piovesan LM, Werneck LC. Paradoxical weight gain after introduction of topiramate associated to fluoxetine withdrawal. Migrâneas cefaléias 2004;7:27-9.